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Abstract
The ‘‘classical model’’ for sexually transmitted infections treats partnerships as instantaneous events summarized by partner
change rates, while individual-based and pair models explicitly account for time within partnerships and gaps between
partnerships. We compared predictions from the classical and pair models over a range of partnership and gap
combinations. While the former predicted similar or marginally higher prevalence at the shortest partnership lengths, the
latter predicted self-sustaining transmission for gonorrhoea (GC) and Chlamydia (CT) over much broader partnership and
gap combinations. Predictions on the critical level of condom use (Cc) required to prevent transmission also differed
substantially when using the same parameters. When calibrated to give the same disease prevalence as the pair model by
adjusting the infectious duration for GC and CT, and by adjusting transmission probabilities for HIV, the classical model then
predicted much higher Cc values for GC and CT, while Cc predictions for HIV were fairly close. In conclusion, the two
approaches give different predictions over potentially important combinations of partnership and gap lengths. Assuming
that it is more correct to explicitly model partnerships and gaps, then pair or individual-based models may be needed for GC
and CT since model calibration does not resolve the differences.
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Introduction
Mathematical models have been used to investigate the
transmission dynamics of sexually transmitted infections (STIs)
and assess the potential impact of public health interventions on
both bacterial and viral STIs, such as the efficacy of screening
measures on reducing Chlamydia prevalence [1,2], and the effect
of anti-retroviral therapy on incident HIV infections [3,4].
Much of this modelling relies on variants of the ‘‘classical
model’’ for STIs proposed by Hethcote and Yorke in the early
1980s [5]. The classical model describes populations of individuals
with different rates of acquisition of new sexual partners (partner
change rates, R). However, this modelling approach is not without
its limitations. Firstly, the manner in which the model describes
‘‘sexual mixing’’ is possibly too simplistic. By comparing several
modelling approaches, Eames and Keeling showed that account-
ing for contact network heterogeneities produces results that are
different and likely more realistic [6]. A separate limitation relates
to how the classical model treats all partnerships as instantaneous
events, often with per partnership transmission probabilities that
are independent of partner change rates. Some modelling studies
have pointed out that individuals with higher partner change rates
would likely have have have have shorter partnerships with fewer
episodes of sexual intercourse within each partnership, and hence
could theoretically have a lower probability of transmitting a given
STI per partner than individuals with lower partner change rates
and correspondingly longer partnerships [7,8]. Much work with
classical models now accounts for different partnership types (e.g.
shorter casual partnerships versus longer stable partnerships), in
effect assuming lower per partnership transmission probabilities
for those with higher partner change rates [1,9,10,11], but it is not
clear if such modifications sufficiently counteract the limitations
associated with modelling partnerships as instantaneous events.
Alternative approaches to treating partnerships as instantaneous
events involves the use of pair models, which were proposed by
Dietz and Hadeler in the late 1980 s [12], and individual-based
models which followed in late 1990 s [13,14]. Both approaches
explicitly account for the duration of partnerships and the duration
spent between partnerships (henceforth referred to as partnership
(v) and gap (w) lengths respectively). Previous work by Chen et al.
suggests substantial variability of partnership and gap lengths at
the population level; by using a pair model, they also showed that
stratifying a population into various categories of partnership and
gap lengths has important implications on the transmission
dynamics of gonorrhoea [15]. In addition, different contexts for
STI transmission may be characterised by different partnership
and gap length combinations. For instance, sex worker client
interactions would be characterised by single episodes of sex
between individuals, interspersed with extremely short gaps in the
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length gaps in the client (of several weeks to months) [16,17];
romantic partnerships in young heterosexuals may comprise
largely intermediate gap and partnership lengths on the order of
a few months [18]; while the transmission context for heterosexual
HIV in parts of Africa appears to involve both shorter as well as
longer stable partnerships on the order of several months to years
[19]. Accurately modelling the effect of partnership and gap
lengths may hence be important for understanding the types of
STIs likely to persist in different risk populations as well as predict
the effect of potential interventions.
Explicitly modelling partnerships and gaps, as is done in pair
and individual-based models, is intuitively more accurate, and
work on pair models suggests that doing so results in different
predictions from what would be expected from the classical model.
Lloyd-Smith and colleagues suggested that this was particularly for
bacterial STIs (which are mostly susceptible-infectious-susceptible
(S-I-S) type infections with a shorter duration of infectiousness)
than for viral STIs (which are mostly susceptible-infectious (S-I)
type infections with a longer duration of infectiousness) [20].
However, Kretzschmar and Dietz also pointed out that, for the
same set of model parameter values, different epidemic growth
rates and steady-state prevalence (p
s) can result when modelling S-
I type pathogens with the two different model formulations [21].
However, neither work considered whether the results would be
more similar if model outputs had been calibrated to observed
data by allowing model parameter values to vary, as is done in
much modelling work (e.g. [1,4,9,22]). One recent paper suggests
that, when modelling Human Papilloma Virus, both the pair and
classical model formulations produce reasonably similar predic-
tions on the impact of vaccination, provided transmission rates are
first calibrated to match the same empirical data on pre-
vaccination prevalence [23]. However, it remains unclear if model
calibration can reduce the discrepancy in predictions when applied
to other STIs, and for what types of sexual behaviour (framed in
terms of partnership and gap lengths). In particular, re-infection
within partnerships can prolong the infectious duration of S-I-S
type infections, a phenomena not adequately accounted for within
the classical model [24].
In this work, we aim firstly to identify the context, both in terms
of disease types and sufficiently broad combinations of partnership
and gap lengths, when the classical model `s assumption of
instantaneous partnerships may produce different predictions
from those derived when explicitly modelling partnerships and
gaps. We do so by using simplified versions of the classical and pair
models to predict p, the prevalence of infection, and Cc, the critical
amount of condom use needed to prevent self-sustaining
transmission. This was done for model parameters depicting
gonococcus (GC) and Chlamydia trachomatis (CT) infections, as
examples of S-I-S type infections with different reproductive
potentials [25]. We also modelled HIV in the absence and
presence of co-factor enhancement, represented respectively as an
S-I type infection with lower and higher estimates of per-sex-act
transmission probability [26]. Secondly, by assuming that explic-
itly modelling partnerships and gaps is more correct, we
investigate whether and when model calibration for the classical
model reduces the divergence in predictions for each partnership
and gap length combination. To approximate situations when
model outputs are calibrated to disease prevalence data, we first
altered one key infection parameter by an adjustment factor (a)s o
that the classical model could reproduce the prevalence predicted
by the pair model, then estimated again the predicted critical
condom use (Cc’) using the classical model with the ‘‘calibrated’’
parameter. We conclude by pointing out situations where
predictions from the classical and pair model diverge substantially
in spite of model calibration, as these contexts would be where
more complex modelling approaches such as pair and individual-
based models may be needed.
Results
Using the baseline parameters in Table 1, Figure 1 contrasts the
predictions from the pair and classical model formulations for the
steady-state prevalence (p
s) for GC and CT, and the peak
prevalence (p
p) for HIV with and without cofactor enhancement
over various combinations of partnership and gap lengths (for an
explanation of why peak prevalence is used in HIV, see methods
and Figure S1). For GC and CT, we see that predictions on p
s
begin to diverge substantially for anything but very short
partnership lengths (less than 10 days). For the longer gap lengths
(30 days for both, and 90 days for CT only), the classical model
gives a higher value of p
s than the pair model at lower partnership
lengths and vice-versa as partnership lengths increase, the cross-
over occurring at 8 days for a gap length of 30 days in GC, and at
14 and 48 days for gap lengths of 30 and 90 days respectively for
CT. The lower values of p
s at combinations of shorter partnership
lengths and longer gap lengths in the pair model is partly due to
the explicit inclusion of the pair-formation process which reduces
opportunities for infectious contacts (for an elaboration, see
discussion and [27]); at longer partnership lengths, this effect is
offset by the potential re-infection within intermediate to longer
partnerships, which is accounted for in the pair model but ignored
in the classical model. For S-I type infections, where re-infection
does not apply, the inclusion of the pair-formation process results
in the pair model predicting lower values of p
p for HIV without
cofactor enhancement (HIV CF-) throughout. For HIV with
cofactor enhancement (HIV CF+), however, a crossover in the
predictions of the pair and classical models occurs (at 299 and
899 days for gap lengths of 30 and 90 days respectively). In this
case, HIV-induced mortality is resulting in additional pair
separation of HIV concordant pairs in what would otherwise be
very long and stable partnerships, an effect which was ignored
classical model.
Figure 2 explores Cc, the critical level of condom use predicted
to prevent self-sustaining transmission (i.e. so that effective
reproduction number is less than 1) when using the pair model
(Figures 2A to D), the classical model (Figures 2E to H), and a
classical model which has been calibrated to give the same values
of p
s and p
p as the pair model (2I to L); for simplicity, condoms
were assumed to have 100% efficacy so that 100% condom use
would prevent all transmission. Predicted Cc values are given by a
colour gradient from 0% (blue) to 100% (red); Cc values of 0% also
demarcate the most extreme combination of partnership and gap
lengths which can support self-sustaining transmission. For all the
four infection parameter sets, both the pair and classical models
predict that the longest permissible gap length occurs at some
partnership length between the extremes of values modelled.
However, the classical model predicts a much more restricted
range of partnership and gap combinations for self-sustaining
transmission of GC and CT than the pair model. Both approaches
predict maximum permissible gap lengths of similar magnitude,
with the values for CT being substantially longer than for GC.
However, even with extremely short gap lengths, permissible
partnership lengths extend only up to 100 and 248 days
respectively in the classical model. On the other hand, the pair
model predicts that intermediate to longer partnership lengths of
up to 724 day for GC and 1150 days for CT could still support
self-sustaining transmission. For HIV without cofactor enhance-
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of permissible partnership lengths of up to 1000 and gap lengths of
up to 140 days, while the corresponding values for the pair model
are 617 and 48 days. For HIV with cofactor enhancement, the
maximum permissible gap length is less in the pair model as
compared to the classical model (671 vs. 1138 days), but the
maximum permissible partnership length is much greater
(8390 days vs. 2786 days; extends into the truncated area in
figure 2D and 2H) due to the additional pair separation from
HIV-induced mortality that arises when HIV involves long stable
partnerships.
With regards to the critical level of condom use which prevents
self-sustaining transmission, both the pair and classical model
formulations predict the same general pattern of decreasing Cc
with increasing gap length, but the exact predictions differ. In the
overlapping combinations where both models predict self-sustain-
ing transmission, the classical model generally predicts higher Cc
values; for example, for GC at a partnership length of 30 days and
a gap length 30 days, the corresponding predictions for Cc are
0.7704 and 0.6984 in the classical and pair models respectively.
Assuming the pair model more accurately predicts disease
prevalence and the partnership and gap combinations where self-
sustaining transmission is possible, the classical models for GC and
CT were calibrated to give the same values of p
s as the pair model
by adjusting the duration of the non-care-seeking infections
(Figures 2I to 2J). After calibration, the classical model now
predicts higher Cc values at longer partnership lengths, the effect
being more pronounced for GC than for CT. The calibrated
classical model also predicts that close to 100% condom use would
be required to prevent self-sustaining transmission for a wide range
Table 1. Model parameters.
Parameter [Reference] Symbol Value
Frequency of sex [9,15] f 1 in 3 days
Sexually active life-span m 35 years
Efficacy of condom use [1] e 0.9
Duration of infectiousness, gonorrhoea [32]
- symptomatic males that receive treatment 1/s1
M 13 days
- symptomatic females that receive treatment 1/s1
W 20 days
- males and females who do not receive treatment 1/s2
M, 1/s2
W 185 days
Proportion which are symptomatic and receive treatment, gonorrhoea [38]
- male h1
M 0.59
- female h1
W 0.36
Per sex act transmission probability, gonorrhoea [42,43]
- male-to-female b
M 0.50
- female-to-male b
W 0.25
Per sex act transmission probability, Chlamydia ([45] see text)
- male-to-female b
M 0.33
- female-to-male b
W 0.06
Duration of infectiousness, Chlamydia [44]
- symptomatic males and females that receive treatment 1/s1
M, 1/s1
W 35 days
- males and females who do not receive treatment 1/s2
M, 1/s2
M 300 days
Proportion which are symptomatic and receive treatment, Chlamydia [38]
- male h1
M 0.09
- female h1
W 0.24
Per sex act transmission probability,
HIV without cofactors [9]
- acute stage b1 0.0107
- chronic stage b2 0.0008
- advanced stage b3 0.0042
Per sex act transmission probability,
HIV with cofactors ([26] see text)
- acute stage b1 0.0428
- chronic stage b2 0.0032
- advanced stage b3 0.0168
Duration of each of HIV stages [9]
- acute stage 1/s1 2.5 months
- chronic stage 1/s2 7.59 years
- advanced stage 1/s3 2.0 years
doi:10.1371/journal.pone.0039575.t001
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predictions of the pair and calibrated classical model is elaborated
on in Figures 3A and B, which highlight the areas where the
absolute difference in predicted Cc values is close to 100% for GC
(i.e. combinations when Cc approaches the maximum of 100% in
the calibrated model and is close to 0% in the pair model).
However, Figures 3E and F show that the corresponding
adjustment factors used in the calibrated classical model are at
the edge of plausibility, since a approaches 10 for GC, and 7.5 for
CT at longer partnership lengths, in effect assuming infectious
periods in the realm of several years. In contrast, after the classical
model for HIV was calibrated by adjusting per sex act
transmission probabilities, predicted Cc values are fairly close to
those from the pair model (Figures 2K and 2L); differences are less
Figure 1. Predictions from the classical and pair model formulations for the steady-state p
sof GC/CT (A and B), and the peak p
p of
HIV with and without cofactor enhancement (C and D). The horizontal axes give partnership length in days while the vertical axes give p. The
different lines denote predictions from using gap lengths (1=q) of 1 day, 7 days, 30 days and 90 days. The inset in each figure magnifies crossover
point, if any, in the region where the classical and pair models diverge in p predictions. Models in (A) and (C) are unable to provide predictions at a
gap length of 90 days.
doi:10.1371/journal.pone.0039575.g001
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10% for most partnership and gap combinations for HIV with
cofactor enhancement (Figures 3C and 3D). Moreover, adjustment
factors are fairly close to 1 for most combinations of partnership
and gap lengths (Figures 3G and 3H). However, for HIV with
cofactor enhancement, the calibrated model could only be
extended up to partnership lengths of about 1500 days, as the
assumption of higher adjustment factors would have resulted in
Figure 2. Critical level of condom use (Cc) predicted to prevent self-sustaining GC/CT and HIV transmission for the pair (A to D),
classical uncalibrated (E to H), and classical model following calibration of p to the pair model output (I to L). The horizontal axes give
partnership length in days while the vertical axes give gap length in days. Cc values are denoted by a gradient of colours as indicated; values of 0%
demarcate the most extreme combination of partnership and gap lengths which supports self-sustaining transmission, while values above 100% (up
to a theoretical maximum of 111% since condoms are assumed to be only 90% effective in preventing transmission) show partnership and gap
combinations where consistent condom use is insufficient to prevent self-sustaining transmission.
doi:10.1371/journal.pone.0039575.g002
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the primary stage of HIV infection), and it was hence not possible
to replicate the dynamics from the pair model for long stable
partnerships.
Discussion
It has been hypothesized that STIs can broadly be divided into
two groups based on their transmission dynamics: those with short
infectious periods but high transmission probabilities (mostly
bacterial STIs, with S-I-S dynamics) and those with long infectious
periods but low transmission probabilities (mostly viral STIs, with
S-I dynamics) 28]. Using parameters for gonorrhoea and
Chlamydia to represent the former, and parameters for HIV
(with and without cofactor enhancement) to represent the latter,
we compared the traditional classical model against results from
the pair model and found that the two model formulations lead to
very different results on predictions about disease prevalence,
partnership and gap length combinations that support transmis-
sion, and the levels of condom use needed to prevent self-
sustaining transmission. Calibrating the classical model to give
similar outputs for p
s and p
p as the pair model fails to reconcile the
predictions for an S-I-S type infection with gonorrhoea and
Chlamydia-like parameters, but does reduce the differences in
predictions on condom use for an S-I type infection like HIV.
Figure 3. Absolute difference in predicted critical level of condom use (Abs(DCc)) for GC/CT and HIV with and without cofactor
enhancement (A to D), with its corresponding adjustment factor, a(E to H). The horizontal axes give partnership length in days while the
vertical axes give gap length in days. Abs(DCc) is computed from the absolute difference in the corresponding values from Figure 2. Coloured bars in
the left (A to D) and right (E to H) panels give the values of Abs(DCc) and a by the respective gradient of colours.
doi:10.1371/journal.pone.0039575.g003
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colleagues had previously demonstrated that the two model
formulations diverge greatly in predicting epidemic growth rate
under a simplified situation which varied the partner change rate
while assuming the partnership and gap lengths to be of equal
duration [20]. In our case, we independently varied partnership
and gap lengths while looking at predictions on steady-state
prevalence (p
s) and condom use, hence providing several
additional insights with key implications. Firstly, it is worth re-
emphasizing that the pair model identifies a broader spectrum of
behaviours as populations potentially capable of sustaining the
transmission of S-I-S type infections; this would include individuals
with intermediate partnership lengths (on the order of a few
months) combined with short gaps in gonorrhoea (less than
3 months), and short to intermediate gap lengths (up to about
5 months) in Chlamydia [15,24]; the potential transmission of
Chlamydia in populations with longer gap lengths may explain
why CT has a wider distribution range in the population than GC
[29,30,31]. Secondly, we show that, across the range of
partnership and gap lengths investigated, discordance in predic-
tions occurs mainly from intermediate to longer partnership
lengths, with the discordance being greater for gonorrhoea which
has a shorter infectious period than Chlamydia. This helps identify
the combination of disease and behavioural contexts where both
modelling approaches would yield similar results, and where they
might diverge. Thirdly, our work shows that fitting S-I-S models to
data will not resolve the discrepant quantitative predictions which
arise from the choice of model formulation. Logically, either one
or both the model formulations are failing to adequately represent
reality. In particular, Garnett and colleagues have previously
pointed out that the classical model applied to gonorrhoea can
give predictions that are unrealistically sensitive to small changes
in parameter values, and our work adds weight to the previous call
for caution on the interpretation of such results [32]. Assuming
that the areas of divergence between the two approaches does
highlight the limits of the classical model in a given disease context,
then given the restricted range of partnership lengths (less than a
few weeks) for gonorrhoea, it is difficult to think of significant
applications in the heterosexual context for the classical model
other than client sex worker interactions. On the other hand, since
results for Chlamydia are still reasonably similar for partnership
lengths up to a couple of months, the classical framework may still
be adequate for modelling Chlamydia transmission in partnerships
amongst at-risk heterosexual youths like those described by
Bearman et al. [18].
With regards to viral and other STIs with S-I dynamics, our
work shows that, for a less infectious pathogen like HIV without
cofactor enhancement, the classical model predicts a higher peak
prevalence (p
p) and self-sustaining transmission over a wider
combination of partnership and gap lengths. This can be
explained by the reduced opportunities for transmission imposed
by the pair formation mechanism; as previously pointed out by
Kretzschmar [27], susceptible individuals who are single or in
stable partnerships with other susceptible individuals, as well as
infectious individuals paired with other infectious individuals are
all excluded from the transmission process (which occurs only in
pairs where one individual is infectious and another is susceptible).
This leads to slower epidemic growth rates in the pair model [21]
and hence a lower value of p
p for HIV, as well as the need to
assume higher pair formation rates to allow self-sustaining
transmission. However, we also show that, while we get similar
results for HIV with cofactor enhancement at shorter partnership
lengths, the pair model predicts higher values of p
p and greater
potential for self-sustaining transmission at longer partnership
lengths as compared to the classical model; this results from the
dominance of HIV-induced mortality on pair separation at longer
partnership lengths which is unaccounted for in the classical
model. While it is comforting to know that model calibration
seems to resolve the discrepant predictions between the pair and
classical models, it must be remembered we are adjusting the
classical model using individually derived adjustment factors for
each partnership and gap combination, while in practice most
model fitting would involve using some average adjustment factor
for disease transmissibility or other parameter value [23]. The
classical model may thus underestimate the role of long-term
stable partnerships in propagating HIV even when calibrated to
data. Other additional differences have been highlighted by others,
including the prediction of higher epidemic growth rates and
higher estimates on the contribution of acute infectious stages by
the classical model as compared to the pair model [21,33].
As with any modelling work, several limitations and assump-
tions must be acknowledged. Firstly, we must reiterate that our
analysis only highlights the difference in predictions between the
pair and classical models, and does not prove which model
formulation is more accurate. It has been argued that the pair
model is a more correct representation of STI dynamics [12,20],
but what is modelled here is a serially monogamous population
rotating through a fixed partnership and gap length combination
in isolation and in perpetuity. In reality, populations comprise
individuals with a heterogeneous mix of behaviour that changes
with successive partnerships. In addition, concurrent partner-
ships would relax the constraint on individuals to have contacts
with only one partner at a time, and a pair model accounting for
concurrency may be closer in dynamics to the classical
formulation for S-I type infections. On the other hand,
concurrent partnerships increase the potential for re-infection
within partnerships, and may thus exaggerate the differences
between the two model formulations for S-I-S type infections.
One question is how significant re-infections are in prolonging
the duration of S-I-S type infections. Several studies suggest that
some re-infections arise from the same source partner [34,35],
and the effectiveness of expedited partner therapy in reducing
repeat infections emphasizes their importance to such STIs
[36,37]. However, stochastic extinction, partial immunity and
treatment of partners would in reality reduce the effect from re-
infections within partnerships. Concerns may also be raised on
the parameters describing both the sexual behaviour of the
population and the natural history of the various STIs modelled.
For instance, in the absence of sufficiently detailed data on how
the frequency sex might vary with partnership duration, we
assumed that sex occurred at the same frequency in all
partnership lengths, although this is unlikely to be the case in
reality; results from the classical and pair models would be less
divergent if sex is less frequent than we had assumed in longer
partnerships, and vice versa if the reverse is true. Also, for
infection parameters, there have also been no direct estimates for
the per sex act transmission probability of Chlamydia that we
know of, and it has been difficult to accurately measure the
duration of infectiousness, as well as the proportion of incident
infections that are asymptomatic or do not receive treatment for
both gonorrhoea and Chlamydia; this is particularly since such
infections would not be accurately represented in clinic-based
data. Our study used estimates for the proportion of incident
infections which are symptomatic and receive care as derived by
Farley et al. [38], which was based on a case-finding type
strategy, with its inherent limitations; in particular, the Chla-
mydia infections in men receiving treatment with symptoms is
lower than what has typically been assumed in other studies.
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model through an ‘‘adjustment factor’’ could be criticised; this
resulted in the need to assume implausible parameter values for
the S-I-S infections, beyond the bounds of what would normally
be used in modelling studies. However, we did this not because
we intended to use such re-scaled parameters to model the
infection in the classical framework, but more to illustrate the
dangers in calibrating an inappropriate model, and to identify
situations where model calibration might fail to help based on
the assumption that the pair model was more correct. An
alternative approach used by others would be to present the
threshold values for transmission probabilities or infectious
duration for the competing modelling approaches [39], and
highlight the partnership and gap combinations where the
divergence between the two models occurs; this would have
avoided passing judgment as to which approach is more correct.
Finally, while a deterministic pair model was sufficient as a
means of identifying situations where the classical model is most
likely inadequate, descriptions of sexual networks ranging from
those involving heterosexual youths [18] to sex worker client
encounters [40] have revealed high levels of complexity and
heterogeneity, and other work has shown that such network
heterogeneities have an important effect on transmission
dynamics that is inadequately approximated by both the pair
and classical models [6,41]. These observations, along with the
importance of modelling partnership and gap durations demon-
strated in this paper, adds to the impetus for developing efficient
individual-based models which can simultaneously account for
both factors.
In summary, our work suggests that outputs from classical and
pair model formulations are in conflict for a range of gap and
partnership combinations which could possibly support the
transmission of some common STIs. Model calibration may
resolve the discrepancies for S-I type infections, but only for the
very shortest partnerships in S-I-S type infections. If we accept that
the actual transmission process is better modelled by the pair
rather than the classical model, then our findings emphasize the
need to move beyond measuring partner change rates to account
for partnership and gap behaviours, and to adopt STI modelling
approaches which accounts for the effect of partnership and gap
lengths on STI transmission.
Methods
Overview of model structure, infection parameters and
notation used
Both the classical and pair models were deterministic
compartmental models depicting a heterosexual population, N,
with an equal number of males and females, with additional
compartments to represent different infection states; the pair
model also included compartments to represent pairs with
different infection state combinations. The population was
assumed to have a finite sexually active lifespan of duration
(1=m), so that turnover of this sexually active population occurs;
the sexually active lifespan was assumed to be 35 years.
Individuals leaving the sexually active pool are replaced at the
same rate by uninfected individuals. In all formulas, superscripts
denote gender (Mfor males and W for females), while subscripts
are used to denote the infection state.
Gonorrhoea and Chlamydia (GC/CT) were both depicted as
susceptible-infectious-susceptible (S-I-S) type pathogens, where the
infection states were 0 for susceptible, 1for symptomatic infections
that receive treatment, and 2for infections which either result in
symptoms but do not receive treatment, or are completely
asymptomatic; the proportion (h
M
1 , h
W
1 ) who are symptomatic
and receive treatment have shorter infectious periods, (sM
1 , sW
1 ),
while the remainder (h
M
2 ~1{h
M
1 , h
W
2 ~1{h
W
1 ) have longer
infectious periods (sM
2 , sW
2 ). Individuals recover without mortality
and are immediately susceptible to re-infection.
HIV was depicted as a susceptible-infectious (S-I) type pathogen
with three successive stages of durationsi, where i~ 1::3 ½ 
represent primary, chronic, and advanced HIV infection respec-
tively. Susceptible individuals (denoted byi~0) enter the primary
infection stage and progress through stages chronic, and advanced
HIV; individuals with advanced HIV are removed by HIV-
induced mortality, and are not replaced.
The corresponding parameter values used are in Table 1. Sex
within partnerships was assumed to occur at a frequency of once in
3 days, while condoms were assumed for simplicity to be 100%
efficacious in preventing transmission; these are values similar to
those assumed in other studies [1,9,15]. For gonorrhoea, we used
the per-sex-act transmission probabilities estimated from historical
studies [42,43] and the same infectious durations proposed by
Garnett et al. [32]. The proportions which are symptomatic and
receive treatment for gonorrhoea follows the estimates from a
study by Farley and colleagues; we also used the corresponding
estimates for Chlamydia from that study [38]. While there are
some estimates on the infectious durations of Chlamydia [44],
there are no direct estimates of per-sex-act transmission probabil-
ities for Chlamydia; we used the data from Lycke et al. [45] to
obtain some estimate for this parameter, with details being
described in the section on Transmission probabilities for
Chlamydia.
Parameters used to depict the durations of acute, chronic and
advanced stages of HIV infection, and the corresponding per-sex-
act transmission probabilities in these stages follow those proposed
by Abu-Raddad et al. [9,46]. We considered a scenario for HIV
with per-sex-act transmission probabilities which were four times
higher, as cofactors such as ulcerative genital disease have been
estimated to enhance transmission by such an amount [26].
Pair model
The pair model depicts a serially monogamous individuals
cycling through the unpaired and paired states. The letter U with
the corresponding superscripts and subscripts was used to depict
the number of unpaired individuals of a particular gender and
infection state, e.g. for gonorrhoea, UM
0 would be the number of
susceptible unpaired males. The letter P with two subscripts
separated by a comma give the corresponding infection state for
the male followed by the female member of pair, e.g. for HIV,
P0,1is a susceptible male paired with a female with primary HIV
infection.
Pair formation occurs when opposite gender individuals transit
from the unpaired to the paired state at a rate (w) inverse to the
specified gap length, and pair separation occurs when paired
individuals return to the unpaired state at a rate (v) inversely
related to partnership lengths; additional pair separation occurs
from turnover of sexually active individuals and HIV-related
mortality, where one member is removed and the surviving
member is returned to the unpaired state. Transmission potentially
occurs at the instant of pair formation between an infected and an
uninfected individual, in accordance with the infection state
specific per-sex-act probability of transmission (bi) modified by the
proportion of sex acts protected by condom use (C) and condom
efficacy (e). For instance, for HIV:
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Within pairs between a susceptible and infectious member,
potential transmission continues at a rate c; this is based on the
chance of avoiding infection after the number of sex acts, f, that
occurs per unit time, and the respective transmission probabilities
modified by condom use (xi), so that:
ci~1{ 1{xi ðÞ
f
Disease transmission results in transitions between the pairs with
different infection state combinations, as do progression of HIV
infection and recovery from GC/CT in the respective pair models;
progression of and recovery from infection also applies to
individuals in the unpaired state. Pairs of a particular infection
state combination form at a rate proportionate to the availability
of unpaired opposite sex individuals from the respective infection
states, while pair separation returns individuals to the respective
compartments by infection state and gender.
In the GC/CT model, iand j denote the three possible infection
states (0,1,2) of the male and female member of the pair
respectively, 3|3~9compartments for pairs and 3 compartments
for unpaired individuals of each gender as follows:
dPi,j
 
dt~ 1{djxM
i
  
1{dixW
j
  
Fi,jzTi,jzDi,j{
vz2mzsM
i zsW
j zdjcM
i zdicW
j
  
Pi,j
dUM
i
 
dt~ vzm ðÞ Pi,0zPi,1zPi,2 ðÞ z
di NmzsM
1 UM
1 zsM
2 UM
2
  
{ wzmzsM
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i
dUW
j
.
dt~ vzm ðÞ P0,jzP1,jzP2,j
  
z
dj NmzsW
1 UW
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2 UW
2
  
{ wzmzsW
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Fi,j, Ti,j and Di,j are transitions resulting from pair formation,
transmission of infection and disease recovery, where:
Fi,j~UM
i UW
j w
. X
UM
i
  
Ti,j~h
M
i cW
j P0,jzxM
i Fi,0
  
Di,j~di sM
1 P1,jzsM
2 P2,j
  
zdj sW
1 Pi,1zsW
2 Pi,2
  
In all the above, d0~1and di~0 for all other values ofi, so that
certain expressions are active only for the relevant pair compart-
ments; also, h
M
0 ~h
W
0 ~sM
0 ~sW
0 ~0 and xM
0 ~xW
0 ~cM
0 ~cW
0 ~0
since individuals in the susceptible state do not recover from or
transmit the infection. In addition, xM
1::2~b
M 1{eC ðÞ , xW
1::2~
b
W 1{eC ðÞ , cM
1::2~1{ 1{xM
i
   f
, and cW
1::2~1{ 1{xW
j
   f
.
Disease prevalence, p, was expressed as
UM
1 zUM
2 zUW
1 zUW
2 zP0,1zP0,2zP1,0zP2,0
z2 P1,1zP1,2zP2,1zP2,2 ðÞ
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UW
j z
XX
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In all analyses, steady-state GC and CT prevalence (p
s) was
used.
In the HIV, there are 4 possible infection states (0,1,2,3) with a
total of 4|4~16 combinations of pairs and 4 compartments for
unpaired individuals of each gender, as follows:
dPi,j
 
dt~ 1{djxi
  
1{dixj
  
Fi,jzTi,jzDi,j{
vz2mzsizsjzdjcizdicj
  
Pi,j
dUM
i
 
dt~ vzm ðÞ Pi,0zPi,1zPi,2zPi,3 ðÞ z
diNmzsi{1UM
i{1zs3Pi,3{ wzmzsi ðÞ UM
i
dUW
j
.
dt~ vzm ðÞ P0,jzP1,jzP2,jzP3,j
  
z
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j{1zs3P3,i{ wzmzsj
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Fi,j is defined similarly as for GC/CT, while Ti,j and Di,j are
defined differently since all new infections enter via stage 1 and
then experience disease progression, as follows:
Fi,j~UM
i UW
j w
. X
UM
i
  
Ti,j~di{1 cjP0,jzxjF0,j
  
zdj{1 ciPi,0zxiFi,0 ðÞ
Di,j~si{1Pi{1,jzsj{1Pi,j{1
In all the above, d0~1and di~0 for all other values of i; we also
defined several dummy variables and parameters that are set to 0,
including s{1, s0, x0, c0, UM
{1, UW
{1, P{1,0::3 andP0::3,{1.
Disease prevalence, p, was expressed as
UM
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2 zUM
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3
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In the case of HIV, modelling predictions on steady-state
prevalence will vary depending on assumptions about replacement
of at-risk individuals removed from the system due to HIV-related
mortality; moreover, most epidemics are still evolving, and have
not reached their steady-state prevalence, although the prevalence
in some geographical areas and population groups may have
passed their peak. We therefore used the peak value of prevalence
(p
p) predicted by the model in all our analyses.
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The classical model treats partnerships as instantaneous events
with a per-partnership transmission probability (y) commonly
computed by estimating the chance of avoiding infection for the
total sex acts in partnerships of a given length, regardless of the
duration of the infectious stage (e.g. [9,10]). To apply this, we
assumed that sex occurs once upon partnership formation then at
frequency f till the partnership ends. For instance, for each
infectious stage in the HIV model:
yi~1{ 1{xi ðÞ
1zf=v ðÞ
where xi is the stage specific per-sex act transmission probabilities
as modified by condom use; in the classical model formulation of
HIV:
xi~aHbi 1{eC ðÞ
where aH is an ‘‘adjustment factor’’ which has a default value of 1
but can be altered to change the value of p
p from the classical
model (as explained in a subsequent section on calibrating classical
model to pair model outputs).
The partner change rate (r)f o rt h ec l a s s i c a lm o d e li s
approximated by the inverse of the ‘‘cycle length’’, which is
the time taken to cycle through successive gaps and partner-
ships, i.e.:
r~ 1=wz1=v ðÞ
{1
If kM
i and kW
j are the number of males and females of the
respective infection state, then for gonorrhoea and Chlamydia:
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whereh
M
0 ~h
W
0 ~sM
0 ~sW
0 ~0, and as with the pair models,
d0~1and di~0 for all other values ofi; a is again an ‘‘adjustment
factor’’, and in this case we fix aG
0 ~aG
1 ~1 while adjusting aG
2 from
the default value of 1 to adjust the output of p
s from the classical
model, since only the duration of non-care-seeking infections is
altered (more detailed explanation to follow later).
The symbols l
M and l
W define force of infection acting on
males and females respectively, where:
l
M~ry
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, xM~b
M 1{eC ðÞ and likewise
for y
W and xW.
Disease prevalence, p, was expressed
as kM
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state GC/CT prevalence, p
s,u s e di na l la n a l y s e s .
For HIV:
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where several dummy variables and parameters that are set to 0,
including s{1, s0, kM
{1 andkW
{1. Again, l
Mand l
W define force of
infection acting on males and females respectively, where:
l
M~ry 1kW
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where y1::3 are as defined previously andy0~0.
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with the HIV pair model, all analyses refer to the peak prevalence,
p
p, predicted by the model.
Estimating the critical level of condom use
We also determined for the pair model and the classical models
the ‘‘critical level of condom use’’ (Cc). This parameter represents
the proportion of sex acts which would need to be protected (e.g.
by condom use, or some other similar intervention) to prevent the
infection from spreading.
Calibrating classical model to pair model outputs
It is not uncommon in STI modelling work (e.g. [1,4,9,22]) to
calibrate model outputs to observed data by allowing model
parameter values to vary. Our aim was to see if transmission
dynamics in sub-populations, as characterised by particular
combinations of partnership and gap lengths, could be adequately
modelled with the classical approach. Since we lack real data on
sub-population specific for the different diseases, we instead start
with the assumption that the pair model more accurately depicts
transmission dynamics. We then altered one key infection
parameter in the classical model by an adjustment factor (a)s o
that it could reproduce the prevalence predicted by the pair
model. Then, using the classical model with the ‘‘calibrated’’
parameter, we re-estimated the predicted critical condom use (Cc’)
for that partnership and gap length combination.
In the case of GC and CT, model fitting often uses estimates of
prevalence (e.g. [1,47]), so model fitting was performed to
minimize the difference in the value of p
s (see Figure S1A). Re-
infection extends the infectious period of an S-I-S pathogen in the
pair model [24], and there is considerable uncertainty in estimates
on the duration of non-care-seeking infections; we therefore
adjusted the value of p
s for GC/CT by altering this parameter
through an adjustment factor (aG
2 ).
In the case of HIV, there has been a wide variation in estimates
on the per-sex-act transmission probabilities [48]. We therefore
calibrated the classical model to give the same value of p
p (see
Figure S1B) as obtained from the pair model by simultaneously
multiplying the transmission probability across all 3 infectious
stages using the same adjustment factor (aH).
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At the steady-state prevalence for GC and CT, the value in each
of the compartments does not change, i.e.dPi,j
 
dt~0,
dUM
i
 
dt~0 and dUW
j
.
dt~0 in the pair model, and
dkM
i
 
dt~0 and dkW
j
.
dt~0 in the classical model. We solved
the above sets of 15 and 6 simultaneous equations in the pair and
classical models numerically to find the respective steady-state
prevalence, p
s, for each parameter set, as well as to obtain the
adjustment factor (aG
2 ) for a calibrated pair model which would
give the same value of p
s as the pair model; we also verified using
the dynamic version of the model that the simulated values of p
approached the calculated values of p
s after 100,000 model days.
For HIV, the peak prevalence, p
p, was obtained by simulation, as
was the adjustment factor (aH). The solution for the critical level of
condom use (Cc) was also found numerically. All models
implemented using the Java programming language version
1.6.0_26.
Transmission probabilities for Chlamydia
We focused on the case-contact pairs where the index was co-
infected with Chlamydia and gonorrhoea described by Lycke et al.
[45]. Assuming the infections passed from the index to the contact,
we observe the respective per-partnership transmission probabil-
ities for Chlamydia and gonorrhoea in Table 2.
We assumed that both infections could have potentially passed
from the index to the contact, but that neither infection influences
transmissibility of the other, and that the infections were
transmitted around the same time to the contact. Therefore, by
using the per-sex-act transmission probabilities for gonorrhoea as
in Table 1 (b
M and b
W), we can estimate the average number of
sex acts that occurred in order to observe the above per-
partnership probabilities of gonorrhoea transmission as
ln 1{0:643 ðÞ
 
ln 1{b
M   
~1:49 and ln 1{0:766 ðÞ
 
ln 1{b
W   
~5:05 for the partnerships where the index case is male and
female respectively. Then, to observe the respective per partner-
ship transmission probabilities for Chlamydia with the corre-
sponding number of sex acts, the respective per-sex act transmis-
sion probabilities for Chlamydia in those partnerships would thus
be 1{ 1{0:446 ðÞ
1=1:49 ðÞ ~0:33 for males-to-females and
1{ 1{0:277 ðÞ
1=5:05 ðÞ ~0:06 for females-to-males.
The above rests on multiple assumptions, but concurs with the
opinion of various authors that Chlamydia is less transmissible
than gonorrhoea [45,47,49], and was the best that could be done
given the lack of direct estimates.
Supporting Information
Figure S1 Figure S1A and S1B illustrate the classical model
being calibrated to the output of the pair model for GC/CT (A)
and HIV (B) respectively. The horizontal axes give simulation time
in days while the vertical axes give p. For the same arbitrary
partnership and gap lengths, the classical model is calibrated to
give the same steady-state prevalence (p
s) for GC/CT (A), and
peak prevalence (p
p) for HIV, as obtained from the pair model,
with the direction of shift in prevalence from uncalibrated to
calibrated as indicated by the arrow.
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